, -

" - "
, 2017

, . . .

  1. Dominic J. Gessler and Guangping Gao, Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders. Methods Mol Biol. 2016; 1382: 429465. doi:10.1007/978-1-4939-3271-9_30.
  2. Michele Simonato, Jean Bennett, Nicholas M. Boulis, Maria G. Castro, David J. Fink, William F. Goins, Steven J. Gray, Pedro R. Lowenstein, Luk H. Vandenberghe, Thomas J. Wilson, John H. Wolfe, and Joseph C. Glorioso, Progress in gene therapy for neurological disorders, Nat Rev Neurol. 2013 May; 9(5): 277291. doi:10.1038/nrneurol.2013.56.
  3. Emma L Leach, Michael Shevell, Kristin Bowden, Sylvia Stockler-Ipsiroglu, and Clara DM van Karnebeek, Treatable inborn errors of metabolism presenting as cerebral palsy mimics: systematic literature review. Orphanet Journal of Rare Diseases 2014, 9:197, http://www.ojrd.com/content/9/1/197
  4. Fick J, Israel MA, Gene therapy for diseases of the nervous system, West J Med 1994; 161:260-263
  5. Bijoyita Roy, Westley J. Friesen, Yuki Tomizawa, John D. Leszyk, Jin Zhuo, Briana Johnson, Jumyana Dakka, Christopher R. Trotta, Xiaojiao Xue, Venkateshwar Mutyam, Kim M. Keeling, James A. Mobley, Steven M. Rowe, David M. Bedwell, Ellen M. Welch, and Allan Jacobson, Ataluren stimulates ribosomal selection of near-cognate tRNAs to promote nonsense suppression. PNAS, 2016, 44, 12508-12513